Designing of disulfide cyclic peptide for inhibiting polymerase A and B1 (PAC-PB1N) in H1N1 virus using molecular simulation approach

Usman Sumo Friend, Mochammad Arfin Fardiansyah Nasution, Arli Aditya Parikesit, Harry Noviardi, Djati Kirani

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

The drug resistance A/H1N1 flu virus is emerging rapidly. Therefore, looking for potential therapy is very important. PB2, PB and PA are subunits of viral RNA-dependent RNA polymerase (RdRp). They play an important role in viral replication. The PA and PB1 binding sites can be considered as potential targets for the development of new influenza drugs. The peptide inhibitors can be designed specifically due to their highpreferred activity. In this study, the cyclic peptide ligands were designed based on the crystal structure of PAC-PB1Nin the surface of the molecule, resulting 1728 cyclopentadienyl compounds. The MOE 2008.10 software was utilized for molecular docking and dynamics simulation approach, while Lipinski’s Rules of Five were utilized to evaluate the feasibility of drug candidates. Thus, molecular dynamics simulation was applied, in order to facilitate the interaction between the ligand and enzyme. The simulations have successfully produced two cyclopentyl peptides, namely CKKTC and CKTTC, which results in both ligands providing a potent inhibitor of polymerase PAC-PB1Nof Influenza A/2009 (H1N1).

Original languageEnglish
Pages (from-to)122-129
Number of pages8
JournalOnLine Journal of Biological Sciences
Volume16
Issue number3
DOIs
Publication statusPublished - 2016

Keywords

  • Five-ring peptides
  • Influenza A
  • Molecular docking
  • Molecular dynamics
  • Polymerase PA-PB1

Fingerprint

Dive into the research topics of 'Designing of disulfide cyclic peptide for inhibiting polymerase A and B1 (PAC-PB1N) in H1N1 virus using molecular simulation approach'. Together they form a unique fingerprint.

Cite this